Related Experiment Videos
Constant infusions vs. intermittent doses of gentamicin against Pseudomonas aeruginosa in vitro
Abstract:
Comparative studies were performed in vitro to test the advocated superiority of infusion over intermittent injection of aminoglycosides. Pseudomonas aeruginosa was exposed to constant and to continuously decreasing (simulating in vivo kinetics) concentrations of gentamicin. In comparing the effect with similar area-under-the-concentration-vs.-time curves, a substantial difference in killing and regrowth could not be demonstrated. Regrowth occurred only when the gentamicin concentration had continuously decreased below one fourth of the minimal inhibitory concentration for greater than 2 hr. Exposure of P. aeruginosa to gentamicin for 30 min was followed by persistent suppression of bacterial regrowth for 1.4-1.9 hr. Thus, intermittent exposure of P. aeruginosa to gentamicin is as effective as constant exposure in vitro. The demonstrated persistent postantibiotic effect might cover in part the periods between intermittent doses of gentamicin in vivo as well as in vitro.
Insights
Intermittent aminoglycoside injections are as effective as continuous infusions for Pseudomonas aeruginosa. This study found that bacterial regrowth was similar in vitro, suggesting intermittent dosing may be viable.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Aminoglycosides are critical antibiotics for treating severe bacterial infections.
- The optimal administration method (infusion vs. injection) for aminoglycosides remains debated.
- Pseudomonas aeruginosa is an opportunistic pathogen often requiring aggressive antibiotic treatment.
Purpose of the Study:
- To compare the in vitro efficacy of continuous infusion versus intermittent injection of aminoglycosides.
- To evaluate the impact of simulated in vivo pharmacokinetics on aminoglycoside activity.
- To investigate the postantibiotic effect of gentamicin against Pseudomonas aeruginosa.
Main Methods:
- In vitro comparative studies exposing Pseudomonas aeruginosa to gentamicin.
- Simulated constant and continuously decreasing gentamicin concentrations.
- Analysis of bacterial killing and regrowth patterns relative to concentration-time curves.
Main Results:
- No substantial difference in bacterial killing or regrowth was observed between constant and decreasing gentamicin concentrations with similar exposure.
- Bacterial regrowth was noted only when gentamicin levels fell below one-fourth of the minimal inhibitory concentration for over 2 hours.
- A 30-minute exposure to gentamicin resulted in a persistent suppression of bacterial regrowth for 1.4-1.9 hours.
Conclusions:
- Intermittent exposure of Pseudomonas aeruginosa to gentamicin is as effective as constant exposure in vitro.
- The observed postantibiotic effect may explain the efficacy of intermittent aminoglycoside dosing in vivo.
- Findings support the potential for intermittent aminoglycoside administration in clinical settings.